Nexavar (sorafenib; Bayer/Amgen) is a small molecule inhibitor that is currently the only targeted treatment available for first-line hepatocellular carcinoma patients.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!